ETFChannel.com
ABBV Description — AbbVie Inc

AbbVie is a research-based biopharmaceutical company. Co.'s products are focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; as well as other serious health conditions. Co. has medicines in clinical development across immunology, oncology and neuroscience, with additional targeted investment in cystic fibrosis and women's health.

Company Name: 
AbbVie Inc
Website: 
www.abbvie.com
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding ABBV: 
105
Total Market Value Held by ETFs: 
$10,780,487,437.34
Total Market Capitalization: 
$126,010,000,000
% of Market Cap. Held by ETFs: 
8.56%
 ETF   ABBV Weight   ABBV Amount 
 VTI   0.41%   $3,507,048,100         
 VOO   0.49%   $2,498,103,789         
 IVV   0.49%   $945,415,324         
 VTV   0.93%   $796,833,184         
 VYM   1.19%   $424,145,396         
 IWF   0.86%   $400,978,430         
 VHT   2.97%   $317,062,744         
 DGRO   2.28%   $210,465,788         
 VV   0.47%   $114,424,718         
 IVW   0.48%   $114,135,400         
List of all 105 ETFs holding ABBV »
Quotes delayed 20 minutes

Buy (3.11 out of 4)
44th percentile
(ranked lower than approx. 56% of all stocks covered)

Analysts Forecast:
ABBV Price Target

Based on data provided by Zacks Investment Research via Quandl.com

ETFs Holding ABBV | AbbVie Inc | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2019, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.